Abstract:STUDY QUESTION:Can whole genome sequencing (WGS) offer a relatively cost-effective approach for embryonic genome-wide haplotyping and preimplantation genetic testing (PGT) for monogenic disorders (PGT-M), aneuploidy (PGT-A) and structural rearrangements (PGT-SR)?SUMMARY ANSWER:Reliable genome-wide haplotyping, PGT-M, PGT-A and PGT-SR could be performed by WGS with 10× depth of parental and 4× depth of embryonic sequencing data.WHAT IS KNOWN ALREADY:Reduced representation genome sequencing with a genome-wide next-generation sequencing haplarithmisis-based solution has been verified as a generic approach for automated haplotyping and comprehensive PGT. Several low-depth massively parallel sequencing (MPS)-based methods for haplotyping and comprehensive PGT have been developed. However, an additional family member, such as a sibling, or a proband, is required for PGT-M haplotyping using low-depth MPS methods.STUDY DESIGN, SIZE, DURATION:In this study, 10 families that had undergone traditional IVF-PGT and 53 embryos, including 13 embryos from two PGT-SR families and 40 embryos from eight PGT-M families, were included to evaluate a WGS-based method. There were 24 blastomeres and 29 blastocysts in total. All embryos were used for PGT-A. Karyomapping validated the WGS results. Clinical outcomes of the 10 families were evaluated.PARTICIPANTS/MATERIALS, SETTING, METHODS:A blastomere or a few trophectoderm cells from the blastocyst were biopsied, and multiple displacement amplification (MDA) was performed. MDA DNA and bulk DNA of family members were used for library construction. Libraries were sequenced, and data analysis, including haplotype inheritance deduction for PGT-M and PGT-SR and read-count analysis for PGT-A, was performed using an in-house pipeline. Haplotyping with a proband and parent-only haplotyping without additional family members were performed to assess the WGS methodology. Concordance analysis between the WGS results and traditional PGT methods was performed.MAIN RESULTS AND THE ROLE OF CHANCE:For the 40 PGT-M and 53 PGT-A embryos, 100% concordance between the WGS and single-nucleotide polymorphism (SNP)-array results was observed, regardless of whether additional family members or a proband was included for PGT-M haplotyping. For the 13 embryos from the two PGT-SR families, the embryonic balanced translocation was detected and 100% concordance between WGS and MicroSeq with PCR-seq was demonstrated.LIMITATIONS, REASONS FOR CAUTION:The number of samples in this study was limited. In some cases, the reference embryo for PGT-M or PGT-SR parent-only haplotyping was not available owing to failed direct genotyping.WIDER IMPLICATIONS OF THE FINDINGS:WGS-based PGT-A, PGT-M and PGT-SR offered a comprehensive PGT approach for haplotyping without the requirement for additional family members. It provided an improved complementary method to PGT methodologies, such as low-depth MPS- and SNP array-based methods.STUDY FUNDING/COMPETING INTEREST(S):This research was supported by the research grant from the National Key R&D Program of China (2018YFC0910201 and 2018YFC1004900), the Guangdong province science and technology project of China (2019B020226001), the Shenzhen Birth Defect Screening Project Lab (JZF No. [2016] 750) and the Shenzhen Municipal Government of China (JCYJ20170412152854656). This work was also supported by the National Natural Science Foundation of China (81771638, 81901495 and 81971344), the National Key R&D Program of China (2018YFC1004901 and 2016YFC0905103), the Shanghai Sailing Program (18YF1424800), the Shanghai Municipal Commission of Science and Technology Program (15411964000) and the Shanghai 'Rising Stars of Medical Talent' Youth Development Program Clinical Laboratory Practitioners Program (201972). The authors declare no competing interests.TRIAL REGISTRATION NUMBER:N/A.

Genetic Insights through Chinese VTE Pedigree Interpretation Using the ACMG Method: Unraveling Potencial Genetic Risk Factors

Identifying mutation‐driven changes in gene functionality that lead to venous thromboembolism

Comprehensive Preimplantation Genetic Testing by Massively Parallel Sequencing

Whole Exome Sequencing Identifies Genetic Variants in Chinese Han Pregnant Women with Venous Thromboembolism-a Case Control Study

Genetic associations of protein-coding variants in venous thromboembolism

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Whole exome sequencing identifies genetic variants in Chinese Han pregnant women with venous thromboembolism

Construction and optimization of a polygenic risk model for venous thromboembolism in the Chinese population

Common genetic risk factors for venous thrombosis in the Chinese population

Whole Genome Analysis of Venous Thromboembolism: the Trans-Omics for Precision Medicine Program

A genome-wide association study for varicose veins

Polymorphisms in MMP-9 and TIMP-2 in Chinese patients with varicose veins

Digenic Inheritance of PROC and SERPINC1 Mutations Contributes to Multiple Sites Venous Thrombosis

Genome-wide Association Analysis of Venous Thromboembolism Identifies New Risk Loci and Genetic Overlap with Arterial Vascular Disease

Unraveling the Genetic Architecture of Congenital Vertebral Malformation with Reference to the Developing Spine

Multi-ancestry polygenic risk scores for venous thromboembolism

Shared genetic etiology of vessel diseases: A genome-wide multi-traits association analysis

Exome Sequencing Identifies Novel Genetic Variants Associated with Varicose Veins

Identification of TTN As a Novel Candidate Gene for Atrioventricular Block in a Chinese Pedigree by Whole-Exome Sequencing

Identifying potential drug targets for varicose veins through integration of GWAS and eQTL summary data

Genome-wide association analyses identified susceptibility loci for chronic thromboembolic pulmonary hypertension among Chinese population